DermaDetect

Executive Summary

DermaDetect is an Israeli AI-driven dermatology platform that combines computer-vision image analysis with a structured intake questionnaire to deliver rapid, physician-guided skin assessments. Its proprietary models classify over 38 skin conditions with >80% diagnostic accuracy and 97% top-3 accuracy, enabling remote diagnostics for patients, clinicians, and payers. Founded in 2020, the company focuses on improving access, speed, and cost-efficiency in dermatologic care. Despite being at an early platform stage with no disclosed funding rounds, DermaDetect's technology has the potential to address significant unmet needs in teledermatology, particularly in regions with limited access to specialists.

Upcoming Catalysts (preview)

• Q4 2026Regulatory clearance (e.g., CE marking or FDA Class II) for clinical deployment in Europe or US60% success
• Q2 2027Strategic partnership with a major telehealth provider or health system for pilot deployment50% success